Iovance Biotherapeutics Inc
F:2LB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Iovance Biotherapeutics Inc
F:2LB
|
US |
|
Ktesios Real Estate SOCIMI SA
MAD:YKTS
|
ES |
|
B
|
Brunello Cucinelli SpA
SWB:8BU
|
IT |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BOY
|
ES |
|
B
|
BNP Paribas SA
F:BNP
|
FR |
|
R
|
RWE AG
PSE:RWE
|
DE |
|
Koninklijke Philips NV
F:PHI1
|
NL |
|
A
|
AP Moeller - Maersk A/S
XMUN:DP4B
|
DK |
|
Ajinomoto Co Inc
F:AJI
|
JP |
|
C
|
Cerro De Pasco Resources Inc
CNSX:CDPR
|
CA |
|
Unicharm Corp
OTC:UNCHF
|
JP |
|
D
|
Devon Energy Corp
F:DY6
|
US |
|
Industrivarden AB
F:IDVA
|
SE |
|
K
|
Krakatau Steel (Persero) Tbk PT
F:07K
|
ID |
|
F
|
Faurecia SE
MIL:EO
|
FR |
|
A
|
American States Water Co
F:FDK
|
US |
|
BTCS Inc
NASDAQ:BTCS
|
US |
|
D
|
Datadog Inc
F:3QD
|
US |
|
C
|
Carter's Inc
XMUN:HCH
|
US |
|
L
|
Lockheed Martin Corp
XBER:LOM
|
US |
|
Siemens AG
F:SIEB
|
DE |
|
L'Oreal SA
PAR:OR
|
FR |
|
ING Groep NV
AEX:INGA
|
NL |
|
E
|
Enbridge Inc
F:EN3
|
CA |
Bankruptcy Probability
Iovance Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Iovance Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
1.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
430.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
211B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Iovance Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Iovance Biotherapeutics Inc has total debt of 1m USD. This includes both short-term (1m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
